{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:23:36Z","timestamp":1747160616757,"version":"3.40.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01DK069983-02","NRSA 5T32DK751627"],"award-info":[{"award-number":["5R01DK069983-02","NRSA 5T32DK751627"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Davis Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.euroneuro.2015.05.010","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T09:27:21Z","timestamp":1433582841000},"page":"1808-1816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Melanin-concentrating hormone is necessary for olanzapine-inhibited locomotor activity in male mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Melissa J.S.","family":"Chee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-3174","authenticated-orcid":false,"given":"Nicholas","family":"Douris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avery B.","family":"Forrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Monnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Stephen E.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Maratos-Flier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.05.010_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mp.2010.33","article-title":"Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis","volume":"16","author":"Albaugh","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40272-013-0016-6","article-title":"Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis","volume":"15","author":"Almandil","year":"2013","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.1203-05.2006","article-title":"Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons","volume":"26","author":"Alon","year":"2006","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11920-012-0287-6","article-title":"Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials","volume":"14","author":"Brewerton","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib5","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/cne.23273","article-title":"Neurochemical characterization of neurons expressing melanin-concentrating hormone receptor 1 in the mouse hypothalamus","volume":"521","author":"Chee","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib6","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1523\/JNEUROSCI.4712-05.2006","article-title":"Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens","volume":"26","author":"Chen","year":"2006","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/157015909788848893","article-title":"Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements","volume":"7","author":"David","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.psychres.2005.11.006","article-title":"Anorexia nervosa with excessive exercise: a phenotype with close links to obsessive\u2013compulsive disorder","volume":"142","author":"Davis","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-440X(97)90927-5","article-title":"The prevalence of high-level exercise in the eating disorders: etiological implications","volume":"38","author":"Davis","year":"1997","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib10","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/sj.ijo.0802079","article-title":"Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague\u2013Dawley rats","volume":"26","author":"Della-Zuana","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib11","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1007\/BF03327760","article-title":"Olanzapine use in adolescent anorexia nervosa","volume":"11","author":"Dennis","year":"2006","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.biopsych.2012.10.025","article-title":"Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance","volume":"73","author":"Dubreucq","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1345\/aph.1H297","article-title":"The role of olanzapine in the treatment of anorexia nervosa","volume":"41","author":"Dunican","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/1098-108X(198323)3:1<27::AID-EAT2260030104>3.0.CO;2-T","article-title":"A theory of activity-based anorexia","volume":"3","author":"Epling","year":"1983","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib15","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/S0014-2999(98)00285-4","article-title":"Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors","volume":"349","author":"Farnbach-Pralong","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib16","first-page":"2933","article-title":"The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance","volume":"25","author":"Georgescu","year":"2005","journal-title":"Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib17","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.euroneuro.2014.07.004","article-title":"Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice","volume":"24","author":"Gomez-Sintes","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib18","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1152\/ajpendo.00350.2002","article-title":"Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone","volume":"284","author":"Gomori","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1126\/science.8091209","article-title":"The basal ganglia and adaptive motor control","volume":"265","author":"Graybiel","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbr.2009.09.032","article-title":"Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance","volume":"207","author":"Guesdon","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib21","doi-asserted-by":"crossref","first-page":"R469","DOI":"10.1152\/ajpregu.90556.2008","article-title":"Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure","volume":"296","author":"Guesdon","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biopsych.2005.04.008","article-title":"Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa?","volume":"58","author":"Hillebrand","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0028-3908(81)90038-1","article-title":"Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat","volume":"20","author":"Jones","year":"1981","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib24","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.4088\/JCP.12r07691","article-title":"Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis","volume":"73","author":"Kishi","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib25","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2012.7","article-title":"Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice","volume":"37","author":"Klenotich","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1152\/jn.00281.2011","article-title":"D(2)-like dopamine receptors differentially regulate unitary IPSCs depending on presynaptic GABAergic neuron subtypes in rat nucleus accumbens shell","volume":"107","author":"Kohnomi","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib27","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1152\/ajpregu.00861.2004","article-title":"Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms","volume":"289","author":"Kokkotou","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib28","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1523\/JNEUROSCI.2163-04.2004","article-title":"Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum","volume":"24","author":"Koos","year":"2004","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/cap.2009.0072","article-title":"Low-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hyperactivity","volume":"20","author":"Leggero","year":"2010","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2826.2006.01415.x","article-title":"Regulation by orexin of feeding behaviour and locomotor activity in the goldfish","volume":"18","author":"Nakamachi","year":"2006","journal-title":"J. Neuroendocrinol."},{"year":"2001","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.euroneuro.2015.05.010_bib32"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biopsych.2007.12.011","article-title":"Dysregulation of the mesolimbic dopamine system and reward in MCH-\/-mice","volume":"64","author":"Pissios","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(99)00859-6","article-title":"The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds","volume":"388","author":"Prinssen","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1124\/jpet.105.089326","article-title":"Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine","volume":"315","author":"Rasmussen","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/sj.npp.1301239","article-title":"The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy","volume":"32","author":"Rasmussen","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0893-133X(95)00196-K","article-title":"Effects of olanzapine on regional C-Fos expression in rat forebrain","volume":"14","author":"Robertson","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(98)00391-4","article-title":"Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine","volume":"353","author":"Sebens","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib39","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/25341","article-title":"Mice lacking melanin-concentrating hormone are hypophagic and lean","volume":"396","author":"Shimada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0031-9384(03)00103-3","article-title":"Animal models in the investigation of anorexia","volume":"79","author":"Siegfried","year":"2003","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.pnpbp.2007.10.003","article-title":"Antipsychotic drug administration differentially affects [3H]muscimol and [3H]flunitrazepam GABA(A) receptor binding sites","volume":"32","author":"Skilbeck","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0893-133X(94)00130-R","article-title":"Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons","volume":"14","author":"Stockton","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.conb.2004.10.003","article-title":"Functional diversity and specificity of neostriatal interneurons","volume":"14","author":"Tepper","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib44","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/diabetes.47.11.1687","article-title":"Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus","volume":"47","author":"Tritos","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2015.05.010_bib45","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1152\/jn.2002.88.3.1263","article-title":"Inhibitory interactions between spiny projection neurons in the rat striatum","volume":"88","author":"Tunstall","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib46","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1017\/S1461145712001642","article-title":"Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function","volume":"16","author":"Vinish","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00517980","article-title":"Motor activity of rats following intracerebral injections of drugs influencing GABA mechanisms","volume":"302","author":"Wachtel","year":"1978","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1152\/jn.90806.2008","article-title":"Presynaptic actions of D2-like receptors in the rat cortico-striato-globus pallidus disynaptic connection in vitro","volume":"101","author":"Watanabe","year":"2009","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib49","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1523\/JNEUROSCI.3921-12.2013","article-title":"Ablation of neurons expressing melanin-concentrating hormone (MCH) in adult mice improves glucose tolerance independent of MCH signaling","volume":"33","author":"Whiddon","year":"2013","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.05.010_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.regpep.2004.06.026","article-title":"Enhanced running wheel activity of both Mch1r- and Pmch-deficient mice","volume":"124","author":"Zhou","year":"2005","journal-title":"Regul. Pept."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T05:03:29Z","timestamp":1566795809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0924977X15001662"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.05.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanin-concentrating hormone is necessary for olanzapine-inhibited locomotor activity in male mice","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}